Pricing
Login
Home
Charts
Search
Watchlist
Products

IOL Chemicals & Pharmaceuticals Ltd

IOLCP
₹184.12-3.99%20 Nov 2026
Reports
Pharma API

IOL Chemicals & Pharmaceuticals Ltd

IOLCP
₹184.12
-3.99%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹5,404Cr
Close
Close Price
₹184.12
Industry
Industry
Pharma API
PE
Price To Earnings
26.61
PS
Price To Sales
1.96
Revenue
Revenue
₹2,751Cr
Rev Gr TTM
Revenue Growth TTM
26.76%
PAT Gr TTM
PAT Growth TTM
75.41%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
520504502526523528552568580619756795
Growth YoY
Revenue Growth YoY%
-0.6-14.2-10.8-3.60.64.79.88.010.917.437.140.1
Expenses
ExpensesCr
476454451484476465490510523527653686
Operating Profit
Operating ProfitCr
44505142476362575792103109
OPM
OPM%
8.59.810.27.99.011.911.310.19.914.913.713.8
Other Income
Other IncomeCr
88764577-6286
Interest Expense
Interest ExpenseCr
432444434345
Depreciation
DepreciationCr
161617181919202020202122
PBT
PBTCr
323740262845464028718787
Tax
TaxCr
91010771312117182222
PAT
PATCr
232830192131343021536465
Growth YoY
PAT Growth YoY%
-2.9-57.4-34.6-49.4-11.113.813.256.50.269.289.8117.1
NPM
NPM%
4.45.56.03.63.96.06.25.33.58.68.58.2
EPS
EPS₹
0.80.91.00.70.71.11.21.00.71.82.22.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
520504502526523528552568580619756795
Growth YoY
Revenue Growth YoY%
-0.6-14.2-10.8-3.60.64.79.88.010.917.437.140.1
Expenses
ExpensesCr
476454451484476465490510523527653686
Operating Profit
Operating ProfitCr
44505142476362575792103109
OPM
OPM%
8.59.810.27.99.011.911.310.19.914.913.713.8
Other Income
Other IncomeCr
88764577-6286
Interest Expense
Interest ExpenseCr
432444434345
Depreciation
DepreciationCr
161617181919202020202122
PBT
PBTCr
323740262845464028718787
Tax
TaxCr
91010771312117182222
PAT
PATCr
232830192131343021536465
Growth YoY
PAT Growth YoY%
-2.9-57.4-34.6-49.4-11.113.813.256.50.269.289.8117.1
NPM
NPM%
4.45.56.03.63.96.06.25.33.58.68.58.2
EPS
EPS₹
0.80.91.00.70.71.11.21.00.71.82.22.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,1842,2172,1332,0792,3192,751
Growth
Revenue Growth%
1.5-3.8-2.511.526.8
Expenses
ExpensesCr
1,9261,9911,9021,8772,0502,388
Operating Profit
Operating ProfitCr
258226231202269363
OPM
OPM%
11.810.210.89.711.613.2
Other Income
Other IncomeCr
182630221010
Interest Expense
Interest ExpenseCr
81616151516
Depreciation
DepreciationCr
434663728084
PBT
PBTCr
225189182138184272
Tax
TaxCr
575047374769
PAT
PATCr
168139134101138203
Growth
PAT Growth%
-17.0-3.4-24.836.275.4
NPM
NPM%
7.76.36.34.95.97.4
EPS
EPS₹
5.74.74.63.44.76.9
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,1842,2172,1332,0792,3192,751
Growth
Revenue Growth%
1.5-3.8-2.511.526.8
Expenses
ExpensesCr
1,9261,9911,9021,8772,0502,388
Operating Profit
Operating ProfitCr
258226231202269363
OPM
OPM%
11.810.210.89.711.613.2
Other Income
Other IncomeCr
182630221010
Interest Expense
Interest ExpenseCr
81616151516
Depreciation
DepreciationCr
434663728084
PBT
PBTCr
225189182138184272
Tax
TaxCr
575047374769
PAT
PATCr
168139134101138203
Growth
PAT Growth%
-17.0-3.4-24.836.275.4
NPM
NPM%
7.76.36.34.95.97.4
EPS
EPS₹
5.74.74.63.44.76.9
Sales CAGR
1 Year12%
3 Years2%
5 Years-
TTM27%
EBITDA CAGR
1 Year33%
3 Years6%
5 Years-
TTM58%
PAT CAGR
1 Year36%
3 Years0%
5 Years-
TTM75%
Avg. ROCE
1 Year10%
3 Years10%
5 Years12%
TTM14%
CFO / EBITDA
1 Year80%
3 Years97%
5 Years76%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
595959595959
Reserves
ReservesCr
1,3341,4491,5531,6291,7401,867
Current Liabilities
Current LiabilitiesCr
513456560610690801
Non Current Liabilities
Non Current LiabilitiesCr
5758738598104
Total Liabilities
Total LiabilitiesCr
1,9622,0222,2442,3822,5872,831
Current Assets
Current AssetsCr
1,0819201,1201,1511,2281,366
Non Current Assets
Non Current AssetsCr
8811,1021,1251,2311,3591,464
Total Assets
Total AssetsCr
1,9622,0222,2442,3822,5872,831
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
595959595959
Reserves
ReservesCr
1,3341,4491,5531,6291,7401,867
Current Liabilities
Current LiabilitiesCr
513456560610690801
Non Current Liabilities
Non Current LiabilitiesCr
5758738598104
Total Liabilities
Total LiabilitiesCr
1,9622,0222,2442,3822,5872,831
Current Assets
Current AssetsCr
1,0819201,1201,1511,2281,366
Non Current Assets
Non Current AssetsCr
8811,1021,1251,2311,3591,464
Total Assets
Total AssetsCr
1,9622,0222,2442,3822,5872,831

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
93122290179214
Investing Cash Flow
Investing Cash FlowCr
-121-120-191-154-198
Financing Cash Flow
Financing Cash FlowCr
-2-4-9346-29
Net Cash Flow
Net Cash FlowCr
-29-2670-13
Free Cash Flow
Free Cash FlowCr
-58-8717-3443
CFO To PAT
CFO To PAT%
55.587.9215.6176.7155.7
CFO To EBITDA
CFO To EBITDA%
36.054.2125.788.379.7
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
93122290179214
Investing Cash Flow
Investing Cash FlowCr
-121-120-191-154-198
Financing Cash Flow
Financing Cash FlowCr
-2-4-9346-29
Net Cash Flow
Net Cash FlowCr
-29-2670-13
Free Cash Flow
Free Cash FlowCr
-58-8717-3443
CFO To PAT
CFO To PAT%
55.587.9215.6176.7155.7
CFO To EBITDA
CFO To EBITDA%
36.054.2125.788.379.7

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,0771,6612,1221,7962,1355,404
Price To Earnings
Price To Earnings
12.411.915.817.815.526.6
Price To Sales
Price To Sales
0.90.81.00.90.92.0
Price To Book
Price To Book
1.51.11.31.11.22.8
EV To EBITDA
EV To EBITDA
7.77.68.78.47.715.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.822.325.325.326.726.7
OPM
OPM%
11.810.210.89.711.613.2
NPM
NPM%
7.76.36.34.95.97.4
ROCE
ROCE%
16.212.912.08.510.313.6
ROE
ROE%
12.09.28.36.07.710.6
ROA
ROA%
8.56.96.04.25.37.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,0771,6612,1221,7962,1355,404
Price To Earnings
Price To Earnings
12.411.915.817.815.526.6
Price To Sales
Price To Sales
0.90.81.00.90.92.0
Price To Book
Price To Book
1.51.11.31.11.22.8
EV To EBITDA
EV To EBITDA
7.77.68.78.47.715.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.822.325.325.326.726.7
OPM
OPM%
11.810.210.89.711.613.2
NPM
NPM%
7.76.36.34.95.97.4
ROCE
ROCE%
16.212.912.08.510.313.6
ROE
ROE%
12.09.28.36.07.710.6
ROA
ROA%
8.56.96.04.25.37.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr10,2728,9845,7515,4044,9914,9404,590
Close PriceClose₹1,598.60990.70960.40184.12620.1590.15352.70
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE75.8034.99134.7026.6128.1826.28213.76
Price To SalesPS11.824.164.711.965.682.1627.68
RevenueRevenueCr8692,1611,2212,7518792,286166
Revenue Growth TTMRev Gr TTM%13.4%20.1%26.8%23.0%30.2%
PAT Growth TTMPAT Gr TTM%7.1%16.5%75.4%-2.8%89.5%
Market CapitalizationMkt CapCr10,2728,9845,7515,4044,9914,9404,590
Close PriceClose₹1,598.60990.70960.40184.12620.1590.15352.70
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE75.8034.99134.7026.6128.1826.28213.76
Price To SalesPS11.824.164.711.965.682.1627.68
RevenueRevenueCr8692,1611,2212,7518792,286166
Revenue Growth TTMRev Gr TTM%13.4%20.1%26.8%23.0%30.2%
PAT Growth TTMPAT Gr TTM%7.1%16.5%75.4%-2.8%89.5%
Interviews